BR9813217A - Tetracycles, process for their production and pharmaceutical preparations containing these compounds - Google Patents
Tetracycles, process for their production and pharmaceutical preparations containing these compoundsInfo
- Publication number
- BR9813217A BR9813217A BR9813217-2A BR9813217A BR9813217A BR 9813217 A BR9813217 A BR 9813217A BR 9813217 A BR9813217 A BR 9813217A BR 9813217 A BR9813217 A BR 9813217A
- Authority
- BR
- Brazil
- Prior art keywords
- group
- tetracycles
- compounds
- production
- pharmaceutical preparations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/31—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the six-membered aromatic ring being part of a condensed ring system formed by at least three rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/58—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C255/47—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of rings being part of condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/16—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
- C07C275/20—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C275/22—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/86—Ring systems containing bridged rings containing four rings
- C07C2603/88—Ethanoanthracenes; Hydrogenated ethanoanthracenes
Abstract
Patente de Invenção: <B>"TETRACICLOS, PROCESSO PARA A PRODUçãO DOS MESMOS E PREPARAçõES FARMACêUTICAS CONTENDO ESTES COMPOSTOS"<D>. A invenção refere-se a derivados de tetraciclo [6.6.2.0^ 2,7^.0^ 9,14^] hexadeca 2(7),3,5,9(14), 10, 12-hexaeno de fórmula I em que R1 e R2 são os mesmos ou diferentes e representam hidrogênio ou um átomo de halogênio, X representa hidrogênio e Y representa um grupo -NR3R4 ou um grupo -N^ +^CH~ 3~R3R4 ou X e Y juntos formam um grupo e Z representa um grupo ou um grupo .Invention Patent: <B> "TETRACYCLES, PROCESS FOR THE PRODUCTION OF THE SAME AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS" <D>. The invention relates to tetracycle derivatives [6.6.2.0 ^ 2,7 ^ .0 ^ 9,14 ^] hexadec 2 (7), 3,5,9 (14), 10, 12-hexaene of formula I in that R1 and R2 are the same or different and represent hydrogen or a halogen atom, X represents hydrogen and Y represents a -NR3R4 group or a -N ^ + ^ CH ~ 3 ~ R3R4 group or X and Y together form a group and Z represents a group or a group.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19742014A DE19742014A1 (en) | 1997-09-24 | 1997-09-24 | Use of new and known tetracyclene compounds as phospholipase inhibitors |
PCT/EP1998/006096 WO1999015493A1 (en) | 1997-09-24 | 1998-09-24 | 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9813217A true BR9813217A (en) | 2000-08-29 |
Family
ID=7843387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9813217-2A BR9813217A (en) | 1997-09-24 | 1998-09-24 | Tetracycles, process for their production and pharmaceutical preparations containing these compounds |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1034162A1 (en) |
JP (1) | JP2002505999A (en) |
KR (1) | KR20010024258A (en) |
CN (1) | CN1278789A (en) |
AR (1) | AR019256A1 (en) |
AU (1) | AU9746698A (en) |
BR (1) | BR9813217A (en) |
CA (1) | CA2304879A1 (en) |
DE (1) | DE19742014A1 (en) |
TR (1) | TR200001222T2 (en) |
WO (1) | WO1999015493A1 (en) |
ZA (1) | ZA988711B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPS282602A0 (en) | 2002-06-07 | 2002-06-27 | Garvan Institute Of Medical Research | Method of inhibiting cell proliferation |
US6995181B2 (en) | 2002-07-18 | 2006-02-07 | Bristol-Myers Squibb Co. | Modulators of the glucocorticoid receptor and method |
US7273881B2 (en) | 2004-01-16 | 2007-09-25 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
US7605264B2 (en) | 2004-01-16 | 2009-10-20 | Bristol-Myers Squibb Company | Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
US7253283B2 (en) | 2004-01-16 | 2007-08-07 | Bristol-Myers Squibb Company | Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
US7569689B2 (en) | 2004-01-16 | 2009-08-04 | Bristol-Myers Squibb Company | Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
US7326728B2 (en) | 2004-01-16 | 2008-02-05 | Bristol-Myers Squibb Company | Modulators of glucocorticoid receptor, AP-1, and/or NF-κβ activity and use thereof |
US7625921B2 (en) | 2004-01-16 | 2009-12-01 | Bristol-Myers Squibb Company | Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
US7361654B2 (en) | 2005-01-13 | 2008-04-22 | Bristol-Myers Squibb Co. | Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
US7642273B2 (en) | 2005-01-13 | 2010-01-05 | Bristol-Myers Squibb Company | Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
US7317024B2 (en) | 2005-01-13 | 2008-01-08 | Bristol-Myers Squibb Co. | Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
US7411071B2 (en) | 2005-01-13 | 2008-08-12 | Bristol-Myers Squibb Company | Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
US9498460B1 (en) | 2016-04-06 | 2016-11-22 | King Saud University | Halogenated tetracyclic compounds |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3123618A (en) * | 1964-03-03 | Io-dihydroanthkacene-z | ||
CH426789A (en) * | 1963-10-21 | 1966-12-31 | Geigy Ag J R | Process for the production of new ethanoanthracene derivatives |
NL123295C (en) * | 1963-10-21 | |||
CH429711A (en) * | 1963-10-21 | 1967-02-15 | Geigy Ag J R | Process for the production of new ethanoanthracene derivatives |
US3422104A (en) * | 1964-10-20 | 1969-01-14 | Geigy Chem Corp | 9,10-dihydro-11-amino-alkylene-9,10-ethanoanthracenes |
FR1459843A (en) * | 1965-07-27 | 1966-06-17 | Soc Ind Fab Antibiotiques Sifa | New quaternary ammonium salts derived from 9-ethano-9,10-dihydro-anthracene and method of preparation |
CH482642A (en) * | 1967-10-17 | 1969-12-15 | Geigy Ag J R | Process for the preparation of 11-aminoalkyl-9,10-dihydro-9,10-ethano-anthracenes |
US5039706A (en) * | 1987-11-30 | 1991-08-13 | Du Pont Merck Pharmaceutical Company | Antiinflammatory PLA2 inhibitors |
US5055468A (en) * | 1989-10-30 | 1991-10-08 | G. D. Searle & Co. | Use of bridged tricyclic amine derivatives as anti-ischemic agents |
US5409932A (en) * | 1993-12-09 | 1995-04-25 | Bayer Ag | Piperazine-substituted pyrroloanthracenes |
WO1995033715A1 (en) * | 1994-06-02 | 1995-12-14 | Smithkline Beecham Corporation | Anti-inflammatory compounds |
-
1997
- 1997-09-24 DE DE19742014A patent/DE19742014A1/en not_active Withdrawn
-
1998
- 1998-09-23 AR ARP980104764A patent/AR019256A1/en unknown
- 1998-09-23 ZA ZA9808711A patent/ZA988711B/en unknown
- 1998-09-24 EP EP98951464A patent/EP1034162A1/en not_active Withdrawn
- 1998-09-24 JP JP2000512804A patent/JP2002505999A/en active Pending
- 1998-09-24 BR BR9813217-2A patent/BR9813217A/en not_active IP Right Cessation
- 1998-09-24 CA CA002304879A patent/CA2304879A1/en not_active Abandoned
- 1998-09-24 KR KR1020007003134A patent/KR20010024258A/en not_active Application Discontinuation
- 1998-09-24 AU AU97466/98A patent/AU9746698A/en not_active Abandoned
- 1998-09-24 TR TR2000/01222T patent/TR200001222T2/en unknown
- 1998-09-24 WO PCT/EP1998/006096 patent/WO1999015493A1/en not_active Application Discontinuation
- 1998-09-24 CN CN98811160A patent/CN1278789A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU9746698A (en) | 1999-04-12 |
WO1999015493A1 (en) | 1999-04-01 |
AR019256A1 (en) | 2002-02-13 |
CN1278789A (en) | 2001-01-03 |
TR200001222T2 (en) | 2000-09-21 |
ZA988711B (en) | 2000-03-23 |
EP1034162A1 (en) | 2000-09-13 |
WO1999015493A8 (en) | 1999-05-06 |
CA2304879A1 (en) | 1999-04-01 |
JP2002505999A (en) | 2002-02-26 |
KR20010024258A (en) | 2001-03-26 |
DE19742014A1 (en) | 1999-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9813390A (en) | Compound, process for preparing it, and use of it, pharmaceutical composition, process for preparing it, and, process for effecting immunosuppression | |
EE9900217A (en) | Sulphinic acid derivatives, their preparation and use | |
BR9913592A (en) | Compounds, compound preparation process, and pharmaceutical compositions | |
BR0108871A (en) | Compound, compound preparation process and pharmaceutical composition | |
BR9911771A (en) | Substituted cyclic compounds, a process for their preparation and pharmaceutical compositions containing the same | |
BRPI0215312B8 (en) | compound, use of a compound, pharmaceutical composition, and process for preparing a compound | |
BR9813368A (en) | Compound, process for the preparation of it, and use of it, pharmaceutical composition, and process for effecting immunosuppression. | |
YU13396A (en) | N-(3-benzofuranyl) urea derivatives, methods for preparation thereof, compositions containing them and their application in medicines | |
EP0236140A3 (en) | Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives | |
BRPI0016395B8 (en) | adamantane derivatives | |
FI964473A (en) | Novel amino acid derivatives, process for their preparation and pharmaceutical compositions containing these compounds (II) | |
BR9813217A (en) | Tetracycles, process for their production and pharmaceutical preparations containing these compounds | |
BR9810763A (en) | Absorbent composition for the purification of gases containing acidic components | |
BR9916633A (en) | Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process | |
FI954898A (en) | Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents | |
BR9805031A (en) | Naphthalene compounds, process for their preparation and pharmaceutical compositions containing them. | |
UA35607C2 (en) | oxazolidinonecarboxylic ACID derivatives, a process for the preparation thereof, pharmaceutical composition and a method for the preparation thereof | |
BR9705456A (en) | Heterocyclic compounds, aminomethyl process for their preparation and pharmaceutical compositions that contain them. | |
BR9801448A (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them. | |
BR0106248A (en) | Metalloprotease inhibitors, process for their preparation and pharmaceutical compositions containing the same | |
HK1023346A1 (en) | Novel substituted tetrahyropyridine derivatives, method of preparation and pharmaceutical compositions containing them | |
WO1999033825A8 (en) | N-phenylamide and n-pyridylamide derivatives, method of preparing them and pharmaceutical compositons containing them | |
BR0114258A (en) | 17alphafluoroalkyl steroids, their production process and pharmaceutical compositions containing these compounds | |
DE69801811T2 (en) | ALKYKENDIAMIN DI- OR TRI-ACETIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN COSMETIC COMPOSITIONS | |
ATE293635T1 (en) | STREPTOGRAMINE DERIVATIVES, THEIR PRODUCTION AND PREPARATIONS CONTAINING THEM |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A,6A,7A,8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007. |